• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II AUI STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II AUI STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETUF2514C102E
Medical Device Problem Codes Difficult to Remove (1528); Device Damaged by Another Device (2915)
Health Effect - Clinical Code Device Embedded In Tissue or Plaque (3165)
Date of Event 07/09/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant aui stent graft was implanted in the patient for a chevar procedure in the treatment of a 60mm abdominal aortic aneurysm.It was reported that during the index procedure, the right renal sheath became entangled with the suprarenal stents.After much effort, the physician was able to remove the sheath, however it was fractured and part of the sheath with the wire remains in the patient.The cause of the event was not determined.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
B:5 additional information received; it was reported as per the physician, when the aui device's suprarenal stents were deployed, one of the anchoring pins became lodged inside of the sheath housing.Therefore, the sheath was unable to safely be removed.It was also reported the anchoring pins on the proximal aspect of the suprarenal stent became embedded inside the outer housing of the sheath.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II AUI STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key10401089
Report Number9612164-2020-02880
Device Sequence Number3122107
Product Code MIH
UDI-Device Identifier00643169232570
UDI-Public00643169232570
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/22/2021
Device Model NumberETUF2514C102E
Device Catalogue NumberETUF2514C102E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/09/2020
Supplement Date Received by Manufacturer08/06/2020
Initial Report FDA Received Date08/13/2020
Supplement Report FDA Received Date09/01/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age79 YR
-
-